(Q50746970)

18 March 2018

title

Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcome. (English)

1 reference

18 March 2018

author name string

T T Biss

series ordinal

1

1 reference

18 March 2018

J P Hanley

series ordinal

2

1 reference

18 March 2018

publication date

1 January 2006

1 reference

18 March 2018

published in

Vox Sanguinis

1 reference

18 March 2018

volume

90

1 reference

18 March 2018

issue

1

1 reference

18 March 2018

page(s)

45-52

1 reference

18 March 2018

HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Use of recombinant factor VIIa in hereditary bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Treatment of traumatic bleeding with recombinant factor VIIa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Recombinant activated factor VII for adjunctive hemorrhage control in trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Management of massive blood loss: a template guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Recombinant FVIIa in the management of uncontrolled hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Recombinant activated factor VII for the treatment of life-threatening haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Recombinant factor VIIa for life-threatening post-partum haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Hypothermia, coagulopathy, and acidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

Updates in the management of severe coagulopathy in trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2005.00711.X

10.1111/J.1423-0410.2005.00711.X

21 January 2018

Identifiers

DOI

1 reference

18 March 2018

release_sbhxnv7azngzhantlnoarzu5wu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sbhxnv7azngzhantlnoarzu5wu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

18 March 2018